OpenURL Connection Search

Select item for more details and to access through your institution.

Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P326, doi. 10.1016/j.jalz.2015.07.471
By:
- Kester, Maartje I.;
- Teunissen, Charlotte E.;
- Crimmins, Daniel L.;
- Macy, Elizabeth M.;
- Ladenson, Jack H.;
- Scheltens, Philip;
- van der Flier, Wiesje M.;
- Morris, John C.;
- Holtzman, David M.;
- Fagan, Anne M.
Publication type:
Article
Hetero-α-helical, two-chain coiled-coils. Clam-worm hybrid paramyosins.
Published in:
Biopolymers, 1981, v. 20, n. 5, p. 925, doi. 10.1002/bip.1981.360200507
By:
- Crimmins, Daniel L.;
- Holtzer, Alfred
Publication type:
Article
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.
Published in:
JAMA Neurology, 2015, v. 72, n. 11, p. 1275, doi. 10.1001/jamaneurol.2015.1867
By:
- Kester, Maartje I.;
- Teunissen, Charlotte E.;
- Crimmins, Daniel L.;
- Herries, Elizabeth M.;
- Ladenson, Jack. H.;
- Scheltens, Philip;
- van der Flier, Wiesje M.;
- Morris, John C.;
- Holtzman, David M.;
- Fagan, Anne M.
Publication type:
Article
Double Monoclonal Immunoassay for Quantifying Human Visinin-Like Protein-1 in CSF.
Published in:
Clinical Chemistry, 2017, v. 63, n. 2, p. 603, doi. 10.1373/clinchem.2016.263236
By:
- Crimmins, Daniel L.;
- Herries, Elizabeth M.;
- Ohlendorf, Matthew F.;
- Brada, Nancy A.;
- Garbett, Nichola C.;
- Zipfel, Gregory J.;
- Schindler, Suzanne E.;
- Ladenson, Jack H.
Publication type:
Article
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays.
Published in:
Clinical Chemistry, 2016, v. 62, n. 1, p. 48, doi. 10.1373/clinchem.2015.250563
By:
- Hoofnagle, Andrew N.;
- Whiteaker, Jeffrey R.;
- Carr, Steven A.;
- Kuhn, Eric;
- Tao Liu;
- Massoni, Sam A.;
- Thomas, Stefani N.;
- Townsend, R. Reid;
- Zimmerman, Lisa J.;
- Boja, Emily;
- Jing Chen;
- Crimmins, Daniel L.;
- Davies, Sherri R.;
- Yuqian Gao;
- Hiltke, Tara R.;
- Ketchum, Karen A.;
- Kinsinger, Christopher R.;
- Mesri, Mehdi;
- Meyer, Matthew R.;
- Wei-Jun Qian
Publication type:
Article
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid.
Published in:
2016
By:
- Ju, Yo‐El S.;
- Finn, Mary Beth;
- Sutphen, Courtney L.;
- Herries, Elizabeth M.;
- Jerome, Gina M.;
- Ladenson, Jack H.;
- Crimmins, Daniel L.;
- Fagan, Anne M.;
- Holtzman, David M.;
- Ju, Yo-El S
Publication type:
journal article

Found: 6

Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease.

Hetero-α-helical, two-chain coiled-coils. Clam-worm hybrid paramyosins.

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

Double Monoclonal Immunoassay for Quantifying Human Visinin-Like Protein-1 in CSF.

Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays.

Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid.